PROCEPT BioRobotics PRCT
NASDAQ PRCT
$21.68 +0.95 (+4.58%)
At close: Aug 21, 2026 · 4:00 PM EDT

PROCEPT BioRobotics (PRCT) Gains from Investment Securities (2020 - 2021)

PROCEPT BioRobotics (PRCT) posted quarterly Gains from Investment Securities of -$38000.0 for Q4 2021, down 179.17% year-over-year from $48000.0 in Q4 2020, and down 137.5% quarter-over-quarter from -$16000.0 in Q3 2021.

PROCEPT BioRobotics (PRCT) Gains from Investment Securities (2020 - 2021) Analysis & Trends

PROCEPT BioRobotics (PRCT) has reported Gains from Investment Securities for 2 consecutive years, with -$38000.0 the latest figure, recorded in Q4 2021.

  • In Q4 2021, Gains from Investment Securities fell 179.17% year-over-year to -$38000.0; the TTM figure through Mar 2022 stood at -$78000.0 (changed N/A YoY), while the FY2021 annual figure was -$64000.0, up 65.41% from the prior year.
  • Gains from Investment Securities declined to -$38000.0 in Q4 2021 per PRCT's latest filing, from -$16000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $48000.0 in Q4 2020 and bottomed at -$142000.0 in Q3 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 PROCEPT BioRobotics 1.24 Bn 965.55 Mn 62.38 Mn

Historic Data

Download Data
DateValue
Dec 31, 2021 -38,000.00
Dec 31, 2021 -38,000.00
Sep 30, 2021 -16,000.00
Sep 30, 2021 -16,000.00
Mar 31, 2021 -24,000.00
Mar 31, 2021 -24,000.00
Dec 31, 2020 48,000.00
Dec 31, 2020 48,000.00
Sep 30, 2020 -142,000.00
Sep 30, 2020 -142,000.00